Adherence therapy for medication non-compliant patients with hypertension: A randomised controlled trial

Journal of Human Hypertension

Volumn 26, Issue 2, 2012, Pages 117-126

  Alhalaiqa, F ^a   Deane, K H O ^a   Nawafleh, A H ^a   Clark, A ^a   Gray, R ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

adherence; beliefs about medication; compliance; ISRCTN:99494659; randomised controlled trial; therapy

Indexed keywords

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HEALTH BELIEF; HUMAN; HYPERTENSION; INTENTION TO TREAT ANALYSIS; JORDAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; JORDAN; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; TIME FACTORS; TREATMENT OUTCOME;

EID: 84855829160     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2010.133     Document Type: Article

References (44)

1. World Health Organization, International Society of Hypertension Writing Group. World Health Organiza-tion (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21: 1983-1992.
2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. The Lancet 2005; 365: 217-223. (Pubitemid 40138015)
3. Ezzati M, Lopez A, Rodgers A, Vander Hoorn S, Murray C. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360: 1347-1360. (Pubitemid 35341298)
4. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. The Lancet 2002; 360: 1903-1913. (Pubitemid 35472129)
5. MacMahon S, Peto R, Collins R, Godwin J, Cutler J, Sorlie P et al. Blood pressure, stroke, and coronary heart disease: Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. The Lancet 1990; 335: 765-774. (Pubitemid 20106689)
6. Asia Pacific Cohort Studies Collaboration. Blood pressure indices and cardiovascular disease in the Asia Pacific region: A pooled analysis. Hypertension 2003; 42: 69-75.
7. Williams B, Lindholm L, Sever P. Systolic pressure is all that matters. The Lancet 2008; 371: 2219-2221.
8. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, KannelWB et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345: 1291-1297.
9. Kokubo Y, Kamide K, Okamura T, Watanabe M, Higashiyama A, Kawanishi K et al. Impact of high-normal blood pressure on the risk of cardiovascular disease in a Japanese urban cohort: The Suita Study. Hypertension 2008; 52: 652-659.
10. Kearney P, Whelton M, Reynolds K, Whelton P, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004; 22: 1.19-1.
11. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003, 289.219.2560.
12. Elzubier AG, Husain AA, Suleiman IA, Hamid ZA. Drug compliance among hypertensive patients in Kassala, Eastern Sudan. East Mediterr Health J 2000; 6: 100-105.
13. Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treat-ments: longitudinal study of electronically compiled dosing histories. Br Med J2008; 336: 1114-1117. (Pubitemid 351731741)
14. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens 2008; 10: 348-354.
15. Sluijs E, Dulmen SV, Dijk LV, de Ridder D, Heerdink R, Bensing J. Patient Adherence to Medical Treatment: a Meta Review. Nivel, Utrecht, 2006.
16. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353: 487-497. (Pubitemid 41127293)
17. Nunes V, Neilson J, O'Flynn N, Calvert N, Kuntze S, Smithson H et al. Clinical Guidelines and Evidence Review for Medicines Adherence: Involving Patients in Decisions about Prescribed Medicines and Supporting Adherence. National Collaborating Centre for Primary Care and Royal College of General Practitioners: London, 2009.
18. Haynes R, Ackloo E, Sahota N, McDonald H, Yao X. Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews 2008 (2): Art. No.: CD000011.
19. Schroeder K, Fahey T, Ebrahim S. Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. Cochrane Database of Systematic Reviews 2004 (3): Art. No.: CD004804.
20. Morrison A, Wertheimer AI, Berger ML. Interventions to improve antihypertensive drug adherence: A quantitative review of trials. Formulary 2000; 35: 234-255. (Pubitemid 30163946)
21. Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evalua-tion of a new method for assessing the cognitive representation of medication. Psychol Health 1999; 4: 1-24.
22. Kemp R, Kirov G, Everitt B, Hayward P, David A. Randomised controlled trial of compliance therapy. 18-month follow-up. Br J Psychiatry 1998; 172: 413-419. (Pubitemid 28204550)
23. Belbeisi A, Zindah M, Walke H, Jarrar B, Mokdad A. Assessing risk factors for chronic disease\-Jordan, 2004. MMWR 2006; 55: 653-655. (Pubitemid 43987864)
24. Yousef A-MM, Al-Bakri AG, Bustanji Y, Wazaify M. Self-Medication patterns in Amman, Jordan. Pharmacy World Sci 2008; 30: 24-30. (Pubitemid 350172642)
25. Morisky D, Ang A, Krousel-Wood M, Ward H. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens 2008; 10: 348-354.
26. Capewell S, Ford E, Croft J, Critchley J, Greenlund K, Labarthe D. Cardiovascular risk factor trends and potential for reducing coronary heart disease mortality in the United States of America. Bulletin WHO 2010; 88: 120-130.
27. Prospective Studies Collaboration. Age-specific rele-vance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913.
28. Goldstein MK, Lavori P, Coleman R, Advani A, Hoffman BB. Improving adherence to guidelines for hypertension drug prescribing: cluster-randomized controlled trial of general versus patient-specific recommendations. Am J Managed Care 2005; 11: 677-685. (Pubitemid 41608209)
29. Schroeder K, Fahey T, Hollinghurst S, Peters TJ. Nurse-led adherence support in hypertension: a randomized controlled trial. Family Practice 2005; 22: 144-151. (Pubitemid 40533088)
30. Schedlbauer A, Davies P, Fahey T. Interventions to improve adherence to lipid lowering medication. Cochrane Database ofSystematic Reviews 2010.
31. World Health Organisation. Process of translation and adaptation of instruments, 2007. http://www.who.int/ substance-abuse/research-tools/ translation/en/index. html.
32. Brislin RW. Back-translation for cross-cultural research. J Cross-cultural Psychol 1970; 1: 185-216.
33. Brislin RW. Translation and content analysis of oral and written materials; In: Trialdis HC, Berry JW (eds). Handbook of Cross-cultural Psychology: Methodology Allyn and Bacon Inc: Boston, 1986.
34. Brislin RW, Lonner WJ, Throndike RM. Cross-cultural Research Methods. John Wiley & Sons: New York, 1973.
35. Craven RF, Hirnle CJ. Fundamentals of Nursing. Lippincott Williams and Wilkins: Philadelphia, USA, 2003.
36. Michigan Department of Community Health. Proce-dure for measurement of blood pressure, 2003. http:// www.michigan.gov/documents/BPprocedure-79896-7. pdf.
37. Rubin DB. Multiple Imputation for Nonresponse in Surveys 9th edn. West Sussex, 1987.
38. World Health Organisation. Adherence to long-term therapies evidence for action. Non-communicable Diseases and Mental Health. Adherence to long-term therapies project. World Health Organization, 2003.
39. Law MR, Wald NJ, Morris JK, Jordan RE. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. Br Med J2003; 326: 1427.
40. Ogedegbe G, Chaplin W, Schoenthaler A, Statman D, Berger D, Richardson T et al. A practice-based trial of motivational interviewing and adherence in hyperten-sive African Americans. Am J Hypertens 2008; 21: 1137-1143.
41. Williams B, Poulter N, Brown M, Davis M, McInnes G, Potter J et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004\-BHS IV. J Hum Hypertens 2004; 18: 139-185. (Pubitemid 38425770)
42. Griffiths C, Motlib J, Azad A, Ramsay J, Eldridge S, Feder G et al. Randomised controlled trial of a lay-led self-management programme for Bangladeshi patients with chronic disease. Br J Gen Pract 2005; 55: 831-837. (Pubitemid 41683996)
43. Gaziano TA, Bitton A, Anand S, Weinstein MC. The global cost of nonoptimal blood pressure. J Hypertensi 2009; 27: 1472-1477.
44. Gray R, Leese M, Bindman J, Becker T, Bburti L, David A et al. Adherence therapy for people with schizophrenia. Br J Psychiatry 2006; 189: 508-514.